Is this fast-growing, 5% yielder too cheap to pass up?

Double-digit earnings growth, a dividend yield over 5% and P/E ratio under 10 put this stock at the top of my watch list.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Despite continuing to achieve record levels of profitability, the share price of sub-prime auto lender S&U (LSE: SUS) has fallen 15% over the past year as market commentators have turned negative on the medium-term outlook for its sector. But with its shares now trading at just 9.6 times forward earnings with analysts expecting a 5.3% dividend yield for the year, should investors pile in?

Well, so far the problems that some columnists have found in the sector, such as loan repayments eating up an outsized portion of borrowers’ incomes, haven’t found their way through to S&U’s books. In the company’s latest trading update covering 18 May to 31 July, it increased the volume of new loans by 20% year-on-year (y/y). And it doesn’t appear that its customers are finding the loans burdensome as monthly collections rose 27% y/y and hit a record £10m in June and July.

Strong collections performance and the increasing benefits of scale certainly appear to be setting the stage for an 18th consecutive year of record pre-tax profits. Indeed, investors responded to this morning’s trading update by sending the company’s share price up over 2%, suggesting some are finding analysts’ consensus forecast for a 19% increase in earnings this year to be a bit low.

Now, this doesn’t mean problems in the sector won’t eventually affect the company. Would-be investors should closely follow the company’s impairment rate, which acts as a decent bellwether for the quality of loans S&U is advancing. Last year the impairment rate did rise to slightly over 20% but is still within respectable limits. Furthermore, management blamed increased competition to attract higher-quality customers for the increase in impairments and this argument makes sense as we saw the much larger sub-prime lender Provident Financial attempt to push its way into the sector.

Investing in S&U isn’t without its risks, but the company has a stellar history of shareholder returns, its loan book still looks pretty healthy and even if the economy heads into reverse, the fact that its loans are secured should provide some peace of mind. Given these positives, a high dividend yield, operating margins of 41% last year and an attractive valuation, S&U is certainly on my watch list.

Painting a pretty picture 

Another growth share that I reckon could turn into a very nice income share over the long term is value make-up company Warpaint London (LSE: W7L). As you could probably guess by its name, the company prefers brash designs, colours and names for its products.

The company’s strategy is to figure out the latest trend in make-up, quickly get the factories in China and Europe it sources from to churn out the product and then distribute it to its retail and distributor clients. In 2016, its first as a public company, the ability of its founder-led management team to successfully execute this strategy was on display. Sales rose 21.1% y/y to £27m as it began direct-to-consumer online sales and signed on 49 new clients to take its total to 319.

The beauty of its business model is that by not having to run expensive high street stores the company is very profitable with operating margins around 25%. It’s still early days and the company is highly valued at 17 times earnings but I see plenty of reason to closely follow Warpaint London.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »